QIAGEN NV (QGEN) vs peers

$50.34

Latest weekly close · Market cap $10.4B

QGEN's EV/EBITDA is 15.3x, compared with 28.6x at the middle of 8 peers.

Peer group: Life Sciences Tools & Services. Updated Oct 30, 2026.

QGEN and Life Sciences Tools & Services, ranked by EV/EBITDA
Stock	EV/EBITDA	Own 5-year percentile
QGENQIAGEN NV	15.3×	n/m, not ranked
WATWaters Corporation	54.8×	100
ILMNIllumina Inc	37.9×	99
MTDMettler Toledo	29.4×	77
MEDPMedpace Holdings Inc	29.2×	80
AAgilent Technologies	28.0×	94
TMOThermo Fisher Scientific	27.2×	100
DHRDanaher Corporation	24.0×	56
IQVIQVIA	17.3×	59
Peer median	28.6×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

EV/EBITDA divides enterprise value (market value plus debt, minus cash) by EBITDA over the last twelve months. The peer median leaves out QGEN and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its EV/EBITDA is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive EBITDA have no reading.

QGEN versus the peer median

-46%

QGEN: 15.3×
Peer median: 28.6×
Own 5-year median: n/m

QGEN EV/EBITDA history Calculate QGEN's implied price